输尿管镜下上路尿路上皮癌活检后膀胱复发:一项多中心观察性克隆基因组评估研究

IF 1.4 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Thineskrishna Anbarasan, Sheikh Nissar, Julie Turbitt, Kathryn Walls, Sarah McLuckie, Caroline Clark, Jean-Christophe Bourdon, Joel Tracey, Susan Bray, Atlaf Shamsuddin, Jason Alcorn, Sunjay Jain, Robert Hislop, Chandra Shekhar Biyani, Ghulam Nabi
{"title":"输尿管镜下上路尿路上皮癌活检后膀胱复发:一项多中心观察性克隆基因组评估研究","authors":"Thineskrishna Anbarasan,&nbsp;Sheikh Nissar,&nbsp;Julie Turbitt,&nbsp;Kathryn Walls,&nbsp;Sarah McLuckie,&nbsp;Caroline Clark,&nbsp;Jean-Christophe Bourdon,&nbsp;Joel Tracey,&nbsp;Susan Bray,&nbsp;Atlaf Shamsuddin,&nbsp;Jason Alcorn,&nbsp;Sunjay Jain,&nbsp;Robert Hislop,&nbsp;Chandra Shekhar Biyani,&nbsp;Ghulam Nabi","doi":"10.1177/00369330221134233","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Urinary bladder recurrences (UBRs) after radical nephroureterectomy (RNUx) are a known challenge in patients with upper-tract urothelial cancers (UTUCs). We aim to assess factors associated with UBR and clonal-relatedness with resected UTUC.</p><p><strong>Methods: </strong>Patients who underwent RNUx for UTUC between 1998 and 2015 in five institutions were identified. Clonal relatedness between primary UTUC and subsequent UBR in a sub-cohort was assessed using next-generation sequencing. A Kaplan-Meier curve was used to assess differences in UBR between two groups (with or without ureteroscopic biopsy).</p><p><strong>Results: </strong>Of 267 patients with complete records, 73 (27.3%) had UBR during follow-up. The five-year UBR-free survival in all patients was 64.7%. The five-year UBR-free-survival was inferior in patients who underwent URS biopsy compared with patients who did not undergo ureteroscopic biopsy (49.9% vs 76.4%, <i>p</i> < 0.001). History of bladder tumour (HR, 95% CI; 2.94, 1.73-5.00, <i>p</i> < 0.001), ureteroscopic biopsy (HR, 95% CI; 2.21, 1.38-3.53, <i>p</i> = 0.001) and preoperative urine cytology ≥C3 (HR, 95% CI; 2.06, 1.24-3.40, <i>p</i> = 0.005) were independently associated with UBR. Patients with ureteroscopic biopsy (n = 3/5) showed identical mutational changes for common genes (<i>TP53</i> and <i>FGFR3</i>) between primary UTUC and subsequent UBR.</p><p><strong>Conclusions: </strong>Ureteroscopic biopsy of UTUC is a significant risk factor for UBR. Qualitative clonality assessment showed identical mutational signatures between primary UTUC and UBR.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"68 1","pages":"4-13"},"PeriodicalIF":1.4000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.\",\"authors\":\"Thineskrishna Anbarasan,&nbsp;Sheikh Nissar,&nbsp;Julie Turbitt,&nbsp;Kathryn Walls,&nbsp;Sarah McLuckie,&nbsp;Caroline Clark,&nbsp;Jean-Christophe Bourdon,&nbsp;Joel Tracey,&nbsp;Susan Bray,&nbsp;Atlaf Shamsuddin,&nbsp;Jason Alcorn,&nbsp;Sunjay Jain,&nbsp;Robert Hislop,&nbsp;Chandra Shekhar Biyani,&nbsp;Ghulam Nabi\",\"doi\":\"10.1177/00369330221134233\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and aims: </strong>Urinary bladder recurrences (UBRs) after radical nephroureterectomy (RNUx) are a known challenge in patients with upper-tract urothelial cancers (UTUCs). We aim to assess factors associated with UBR and clonal-relatedness with resected UTUC.</p><p><strong>Methods: </strong>Patients who underwent RNUx for UTUC between 1998 and 2015 in five institutions were identified. Clonal relatedness between primary UTUC and subsequent UBR in a sub-cohort was assessed using next-generation sequencing. A Kaplan-Meier curve was used to assess differences in UBR between two groups (with or without ureteroscopic biopsy).</p><p><strong>Results: </strong>Of 267 patients with complete records, 73 (27.3%) had UBR during follow-up. The five-year UBR-free survival in all patients was 64.7%. The five-year UBR-free-survival was inferior in patients who underwent URS biopsy compared with patients who did not undergo ureteroscopic biopsy (49.9% vs 76.4%, <i>p</i> < 0.001). History of bladder tumour (HR, 95% CI; 2.94, 1.73-5.00, <i>p</i> < 0.001), ureteroscopic biopsy (HR, 95% CI; 2.21, 1.38-3.53, <i>p</i> = 0.001) and preoperative urine cytology ≥C3 (HR, 95% CI; 2.06, 1.24-3.40, <i>p</i> = 0.005) were independently associated with UBR. Patients with ureteroscopic biopsy (n = 3/5) showed identical mutational changes for common genes (<i>TP53</i> and <i>FGFR3</i>) between primary UTUC and subsequent UBR.</p><p><strong>Conclusions: </strong>Ureteroscopic biopsy of UTUC is a significant risk factor for UBR. Qualitative clonality assessment showed identical mutational signatures between primary UTUC and UBR.</p>\",\"PeriodicalId\":21683,\"journal\":{\"name\":\"Scottish Medical Journal\",\"volume\":\"68 1\",\"pages\":\"4-13\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2023-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Scottish Medical Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/00369330221134233\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scottish Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00369330221134233","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 3

摘要

背景和目的:根治性肾输尿管切除术(RNUx)后膀胱复发(UBRs)是上尿路上皮癌(UTUCs)患者的一个已知挑战。我们的目的是评估与UBR相关的因素以及与切除的UTUC的克隆相关性。方法:选取1998年至2015年间在5家医院因UTUC接受RNUx治疗的患者。使用下一代测序评估亚队列中原发性UTUC和随后的UBR之间的克隆相关性。Kaplan-Meier曲线用于评估两组间UBR的差异(有或没有输尿管镜活检)。结果:267例记录完整的患者中,73例(27.3%)在随访期间发生UBR。所有患者的5年无ubr生存率为64.7%。接受尿路穿刺活检的患者5年无ubr生存率低于未接受输尿管镜活检的患者(49.9% vs 76.4%, p p p = 0.001),且术前尿细胞学≥C3 (HR, 95% CI;2.06, 1.24-3.40, p = 0.005)与UBR独立相关。输尿管镜活检患者(n = 3/5)在原发性UTUC和随后的UBR之间显示相同的常见基因(TP53和FGFR3)突变变化。结论:UTUC输尿管镜活检是UBR的重要危险因素。定性克隆性评价显示,原发UTUC和UBR的突变特征相同。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.

Background and aims: Urinary bladder recurrences (UBRs) after radical nephroureterectomy (RNUx) are a known challenge in patients with upper-tract urothelial cancers (UTUCs). We aim to assess factors associated with UBR and clonal-relatedness with resected UTUC.

Methods: Patients who underwent RNUx for UTUC between 1998 and 2015 in five institutions were identified. Clonal relatedness between primary UTUC and subsequent UBR in a sub-cohort was assessed using next-generation sequencing. A Kaplan-Meier curve was used to assess differences in UBR between two groups (with or without ureteroscopic biopsy).

Results: Of 267 patients with complete records, 73 (27.3%) had UBR during follow-up. The five-year UBR-free survival in all patients was 64.7%. The five-year UBR-free-survival was inferior in patients who underwent URS biopsy compared with patients who did not undergo ureteroscopic biopsy (49.9% vs 76.4%, p < 0.001). History of bladder tumour (HR, 95% CI; 2.94, 1.73-5.00, p < 0.001), ureteroscopic biopsy (HR, 95% CI; 2.21, 1.38-3.53, p = 0.001) and preoperative urine cytology ≥C3 (HR, 95% CI; 2.06, 1.24-3.40, p = 0.005) were independently associated with UBR. Patients with ureteroscopic biopsy (n = 3/5) showed identical mutational changes for common genes (TP53 and FGFR3) between primary UTUC and subsequent UBR.

Conclusions: Ureteroscopic biopsy of UTUC is a significant risk factor for UBR. Qualitative clonality assessment showed identical mutational signatures between primary UTUC and UBR.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Scottish Medical Journal
Scottish Medical Journal 医学-医学:内科
CiteScore
4.80
自引率
3.70%
发文量
42
审稿时长
>12 weeks
期刊介绍: A unique international information source for the latest news and issues concerning the Scottish medical community. Contributions are drawn from Scotland and its medical institutions, through an array of international authors. In addition to original papers, Scottish Medical Journal publishes commissioned educational review articles, case reports, historical articles, and sponsoring society abstracts.This journal is a member of the Committee on Publications Ethics (COPE).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信